| Identification | Back Directory | [Name]
2,6-Dichloro-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine | [CAS]
205171-10-4 | [Synonyms]
2,6-Dichloro-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine
2,6-Dichloro-9-(2-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine
2,6-Dichloro-9-(2-b-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine
2,6-DICHLORO-9-(2-C-METHYL-2,3,5-TRI-O-BENZOYL-BETA-D-RIBOFURANOSYL)PURINE
9H-Purine, 2,6-dichloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-
2,6-Dichloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine | [Molecular Formula]
C32H24Cl2N4O7 | [MDL Number]
MFCD25542507 | [MOL File]
205171-10-4.mol | [Molecular Weight]
647.46 |
| Hazard Information | Back Directory | [Uses]
2,6-Dichloro-9-(2-c-methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine dibenzoate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited
|
| Tel: |
+86-0571-86912261 +86-15658003402 |
| Website: |
https://www.newcanbio.com/ |
| Company Name: |
AstaTech, Inc
|
| Tel: |
(215) 785 3197 |
| Website: |
www.astatechinc.com |
|